Skip to content
OpenCapital
Get started

Innovate VATE Life Sciences — Equity method

Similar metrics at other companies

Donaldson Company logo
DCILife Sciences Segment — Equity earnings in unconsolidated affiliates
$0—
Ashland logo
ASHLife Sciences — Income Loss From Equity Method Investments And Other Income Expense
$0—
CNH Industrial N.V. logo
CNHFinancial Services — Equity method
$146M+13.2%
Clorox logo
CLXLifestyle — Income (Loss) from Equity Method Investments
$0—
Tecnoglass logo
TGLSEquity Method Income
$102K-92.4%
Royalty Pharma logo
RPRXEquity Method Investments
$265.7M-21.0%

Other financials

Income statement

See full
Revenue$364.8M+33.0%
Gross profit$53.5M+17.6%
Operating income$10.0M+194%
Net income-$16.8M+31.4%
EPS (diluted)-$1.29+31.7%

Balance sheet

See full
Cash & equivalents$134.6M+297%
Total debt$1.4B+11.6%
Total equity-$256.3M-25.5%
Total assets$936.8M+7.9%

Cash flow

See full
Operating cash flow$45.5M+423%
CapEx$200.0K-95.7%
Free cash flow$45.3M+341%

Valuation

See full
Market cap$254.69M+196%
Enterprise value$1.52B+21.4%
P/S0.2×+0.1×

Profitability

See full
Gross margin15.5%-3.8pp
Operating margin2.6%-1.2pp
Net margin-4%0.0pp
FCF margin15.7%—

Returns & leverage

See full
Return on equity-8.1%—
Debt / equity1.7×—
Current ratio0.4×0.0×

Where this comes from

Reported directly by Innovate in its filing.

Tagged under the XBRL concept us-gaap:EquityMethodInvestments.

The official record: Innovate’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Innovate's life sciences — equity method.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Innovate's life sciences — equity method?
Innovate (VATE) reported life sciences — equity method of $900K in Q1 2026.
How has Innovate's life sciences — equity method changed year-over-year?
Innovate's life sciences — equity method decreased by 0.0% year-over-year, from $900K to $900K.
What is the long-term trend for Innovate's life sciences — equity method?
Over 3 years (2022 to 2025), Innovate's life sciences — equity method has grown at a -48.5% compound annual growth rate (CAGR), from $26.3M to $3.6M.
What does life sciences — equity method mean?
Represents the segment's proportional share of earnings or losses from investments in associates or joint ventures accounted for under the equity method. It provides insight into the segment's collaborative business interests and external partnerships.